This comes on the backdrop of the World Health Organisation (WHO) declaration that the outbreak of monkeypox is a public health emergency of international concern
Initially the WHO was criticised for its deferential approach to China, but in the absence of any compelling evidence of zoonotic spread the process by which a virus leaps from animals to humans the global agency is now adopting a more neutral public stance, the report said.
Indian manufacturers will soon have an opportunity to work with WHO’s COVID-19 Technology Access Pool and the Medicines Patent Pool for developing innovative therapeutics, vaccines and diagnostics against coronavirus.